Hidden disruptions in metabolic syndrome: Drug-induced nutrient depletion as a pathway to accelerated pathophysiology of metabolic syndrome

Alternative Therapies in Health and Medicine

Volumn 12, Issue 2, 2006, Pages 26-31

  LaValle, James B ^a,b  

^a Living Longer Institute   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FOLIC ACID; MAGNESIUM; MELATONIN; POTASSIUM; SODIUM; UBIDECARENONE; ZINC;

COMORBIDITY; CONTINUING EDUCATION; DRUG INDUCED DISEASE; HEALTH STATUS; LIFESTYLE; MAGNESIUM DEFICIENCY; METABOLIC SYNDROME X; NUTRIENT; PATHOPHYSIOLOGY; POLYPHARMACY; PRESCRIPTION; REVIEW; ZINC DEFICIENCY;

ADRENERGIC BETA-ANTAGONISTS; ANTILIPEMIC AGENTS; DEFICIENCY DISEASES; DIURETICS; HUMANS; HYPOGLYCEMIC AGENTS; METABOLIC SYNDROME X; NUTRITIONAL STATUS;

EID: 33644915082     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-2752. Epub 2005 Sep 12.
2. American Heart Association. Metabolic syndrome. Available at http://www.americanheart.org/ presenter.jhtml?identifier=4756. Accessed February 3, 2006.
3. Ramsay LE, Yeo WW, Jackson PR. Metabolic effects of diuretics. Cardiology. 1994;84 Suppl 2:48-56.
4. Rothman R, Weinberger M. The role of pharmacists in clinical care: where do we go from here? [Editorial] Effective Clinical Practice [serial online]. 2002;5(2). Available at: http://www.acponline.org/journals/ecp/pastiss/ma02.htm. Accessed February 2, 2006.
5. Rude RK. Magnesium deficiency: a cause of heterogeneous disease in humans. J Bone Miner Res. 1998;13:749-758.
6. Atsmon J, Dolev E. Drug-induced hypomagnesaemia. Drug Safety. 2005;28(9):763-788.
7. Alaimo K, McDowell MA, Briefel RR, et al. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988-91. Adv Data. 1994;(258):1-28.
8. Pelton R, LaValle JB, Hawkins EB, Krinsky DL. Drug-Induced Nutrient Depletion Handbook, 2nd ed. Hudson, Ohio: Lexi-Comp, Inc; 2001.
9. Pelton R, LaValle JB. The Nutritional Cost of Drugs: A Guide to Maintaining Good Nutrition While Using Prescription and Over-The-Counter Drugs, 2nd ed. Englewood, Colo: Morton Publishing; 2004.
10. Bralley JA, Lord RS. Laboratory Evaluations in Molecular Medicine. Norcross, Ga: The Institute for Advances in Molecular Medicine; 2001.
11. Nair RR, Nair P. Alteration of myocardial mechanics in marginal magnesium deficiency. Magnes Res. 2002;15(3-4):287-306.
12. King DE, Mainous AG 3rd, Geesey ME, Woolson RF. Dietary magnesium and C-reactive protein levels. J Am Coll Nutr. 2005;24(3):166-171.
13. Chaudhary DP, Boparai RK, Sharma R, Bansal DD. Studies on the development of an insulin resistant rat model by chronic feeding of low magnesium high sucrose diet. Magnes Res. 2004;17(4):293-300.
14. Drug Digest Monograph. Available at: www.drugdigest.org/DD/ PrintablePages/ Monograph/0,7765,3251,00.html. Accessed February 2, 2006.
15. Messerli FH, Grossman E. Therapeutic controversies in hypertension. Semin Nephrol. 2005;25(4):227-235.
16. Nadler JL, Buchanan T, Natarajan R, et al. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993;21(6 Pt 2):1024-1029.
17. Krinsky DL, LaValle JB, Hawkins E, Pelton R, Ashbrook Willis N. Natural Therapeutic Pocket Guide, 2nd ed. Hudson, Ohio: Lexi-Comp, Inc; 2003.
18. Linnane AW, Kopsidas G, Zhang C, et al. Cellular redox activity of coenzyme Q10: effect of CoQ10 supplementation on human skeletal muscle. Free Radic Res. 2002;36(4):445-453.
19. Moreira PI, Santos MS, Sena C, et al. CoQ10 therapy attenuates amyloid beta-peptide toxicity in brain mitochondria isolated from aged diabetic rats. Exp Neurol. 2005;196(1):112-119. Epub 2005 Aug 29.
20. Digiesi V, Cantini F, Oradei A, et al. Coenzyme Q10 in essential hypertension. Mol Aspects Med. 1994;15 Suppl:S257-S263.
21. Langsjoen P, Langsjoen P, Willis R, Folkers K. Treatment of essential hypertension with coenzyme Q10. Mol Aspects Med. 1994;15 Suppl:S265-S272.
22. Lamperti C, Naini AB, Lucchini V, et al. Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol 2005;62(11):1709-1712.
23. Bao B, Prasad AS, Beck FW, Godmere M. Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab. 2003;285(5):E1095-102. Epub 2003 Jun 17.
24. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med. 2005;56:45-62.
25. Yamaguchi K, Higashiura K, Ura N, et al. The effect of tumor necrosis factor-alpha on tissue specificity and selectivity to insulin signaling. Hypertens Res. 2003;26(5):389-396.
26. Petersen JL, McGuire DK. Impaired glucose tolerance and impaired lasting glucose-a review of diagnosis, clinical implications and management. Diab Vasc Dis Res. 2005;2(1):9-15.
27. Derosa G, Cicero AF, Gaddi AV, et al. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, doubleblind, randomized clinical trial. Clin Ther. 2005;27(9):1383-1391.
28. Setola E, Monti LD, Galluccio E, et al. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 2004;151(4):483-489.
29. Hayden MR, Tyagi SC. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J. 2004;3:4.
30. Araki A, Hosoi T, Orimo H, Ito H. Association of plasma homocysteine with serum interleukin-6 and C-peptide levels in patients with type 2 diabetes. Metabolism. 2005;54(6):809-814.
31. Bonnet F, Irving K, Terra JL, et al. Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J Hypertens.;23(3):611-617.
32. Tiemeier H, van Tuijl HR, Hofman A, et al. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry. 2002;159(12);2099-2101.
33. Sachdev PS, Parslow RA, Lux O, et al. Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol Med. 2005;35(4):529-538.
34. Picinato MC, Haber, EP, Carpinelli AR, et al. Daily rhythm of glucose induced secretion by isolated islets from the intact and pinealectomized rat. J Pineal Res. 2002;33(3):172-177.
35. NHANES I Data. Findings presented at: Annual Scientific Meeting of the North American Association for the Study of Obesity; Nov 14-18, 2004: Las Vegas, Nev.
36. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846-850. Summary for patients in:
37. Ann Intern Med. 2004;141(11):152.
38. Kunz D, Mahlberg R, Muller C, Tilmann A, Bes F. Melatonin in patients with reduced REM sleep duration: two randomized controlled trials. J Clin Endocrinol Metab. 2004;89(1):128-134.
39. Rajaratnam SM, Middleton B, Stone BM, Arendt J, Dijk DJ. Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans. J Physiol. 2004;561(Pt 1):339-351. Epub 2004 Sep 30.
40. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 2005;99(5):2008-2019.
41. Nishida S. Metabolic Effects of Melatonin on oxidative stress and diabetes mellitus. Endocrine. 2005;27(2):131-136.
42. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine. 2005;27(2):179-188. Review.